Not Sold on Performance Measures
- Bruce E. Landon, MD, MBA; and
- Sharon-Lise T. Normand, PhD
- From Harvard Medical School, Boston, MA 02115.
IN RESPONSE:
We sympathize with the sentiments expressed by Dr. Miller. One of us is a practicing physician and is aware of the extra burden imposed by many performance measurement programs with unclear patient benefits. Evidence suggests, however, that the proliferation, measurement, and dissemination of quality information have a substantial impact on measured areas of quality. Indeed, one measure (β-blocker use after a myocardial infarction) has been retired because performance has approached perfection (1) …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
